Table 2 Comparison of evaluation Metrices for the proposed NNARX and RNN in (Allam et al. 2011a)
PH (min.) | NPE (%) | RMSE (mmol/L) | FIT (%) | |||
|---|---|---|---|---|---|---|
Proposed NNARX | RNN in (Allam et al. 2011a) | Proposed NNARX | RNN in (Allam et al. 2011a) | Proposed NNARX | RNN in (Allam et al. 2011a) | |
15 | 14.1713 | 1.7 | 1.1890 | 0.14 | 79.2484 | 95.33 |
30 | 11.6805 | 5.27 | 0.9117 | 0.42 | 82.9889 | 85.83 |
45 | 10.5562 | 10.28 | 0.7446 | 0.82 | 84.6989 | 72.3 |
60 | 10.6028 | 16.2 | 0.7512 | 1.32 | 84.0512 | 56.61 |
90 | 12.3604 | – | 1.0209 | – | 77.9620 | – |
100 | 13.3 | – | 1.1890 | – | 75.2006 | – |
Standard deviation | 1.330464 | 6.29 | 0.180432 | 0.51 | 2.530228 | 17.01 |